A Comprehensive Evaluation of the Disease-Modifying Effects of Tafamidis in Patients with Transthyretin Type Familial Amyloid Polyneuropathy

被引：0
|
作者：
Coelho, Teresa
Maia, Luis
da Silva, Ana Martins
Cruz, Marcia Waddington
Plante-Bordeneuve, Violaine
Lozeron, Pierre
Suhr, Ole B.
Campistol, Josep
Conceicao, Isabel
Schmidt, Hartmut
Trigo, Pedro
Packman, Jeff
Grogan, Donna R.
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [1] Sustainability of response to tafamidis, a disease-modifying therapy for transthyretin type familial amyloid polyneuropathy
    Coelho, T.
    Maia, L.
    Silva, A.
    Cruz, M. Waddington
    Plante-Bordeneuve, V.
    Suhr, O. B.
    Conceicao, I.
    Schmidt, H.
    Trigo, P.
    Packman, J.
    Grogan, D. R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 35 - 35
  • [2] INFLUENCE OF BASELINE NEUROLOGIC SEVERITY ON DISEASE PROGRESSION AND THE ASSOCIATED DISEASE-MODIFYING EFFECTS OF TAFAMIDIS IN TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY
    Amass, L.
    Li, H.
    Gundapaneni, B.
    Schwartz, J.
    Keohane, D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 235 - 235
  • [3] Tafamidis (Fx-1006A): A First-In-Class Disease-Modifying Therapy for Transthyretin Type Familial Amyloid Polyneuropathy
    Coelho, Teresa
    Maia, Luis
    da Silva, Ana Martins
    Waddington, Marcia
    Plante-Bordeneuve, Violane
    Lozeron, Pierre
    Suhr, Ole B.
    Campistol, Josep
    Conceicao, Isabel
    Schmidt, Hartmut
    Trigo, Pedro
    Packman, Jeff
    Grogan, Donna R.
    NEUROLOGY, 2010, 74 (09) : A286 - A286
  • [4] Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy
    Leslie Amass
    Huihua Li
    Balarama K. Gundapaneni
    Jeffrey H. Schwartz
    Denis J. Keohane
    Orphanet Journal of Rare Diseases, 13
  • [5] Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy
    Amass, Leslie
    Li, Huihua
    Gundapaneni, Balarama K.
    Schwartz, Jeffrey H.
    Keohane, Denis J.
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [6] EARLY-TREATMENT EFFECTS OF TAFAMIDIS IN TRANSTHYRETIN TYPE FAMILIAL AMYLOID POLYNEUROPATHY
    Coelho, T.
    Maia, L.
    da Silva, A. M.
    Cruz, M. W.
    Plante-Bordeneuve, V
    Suhr, O. B.
    Campistol, J.
    Conceicao, I
    Schmidt, H.
    Trigo, P.
    Packman, J.
    Grogan, D. R.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S24 - S25
  • [7] A comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy
    Huber, Peter
    Flynn, Alison
    Sultan, Marla B.
    Li, Huihua
    Rill, Denise
    Ebede, Ben
    Gundapaneni, Balarama
    Schwartz, Jeffrey H.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 (04): : 203 - 209
  • [8] Evaluation of one year treatment with tafamidis in Portuguese patients with transthyretin familial amyloid polyneuropathy
    Coelho, T.
    Conceicao, I.
    Cardoso, M.
    Monteiro, C.
    Alves, C.
    Rodrigues, C.
    Pereira, P.
    Silva, A. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 327 - 327
  • [9] Evaluation of one year treatment with tafamidis in Portuguese patients with transthyretin familial amyloid polyneuropathy
    Coelho, T.
    Conceicao, I.
    Cardoso, M.
    Monteiro, C.
    Alves, C.
    Rodrigues, C.
    Pereira, P.
    Silva, A. M.
    JOURNAL OF NEUROLOGY, 2014, 261 : S221 - S221
  • [10] Tafamidis (Fx-1006A): a first-in-class disease-modifying therapy for transthyretin familial amyloid
    Coelho, T.
    Maia, L.
    Martins da Silva, A.
    Waddingtion-Cruz, M.
    Plante-Bordeneuve, V.
    Lozeron, P.
    Suhr, O. B.
    Campistol, J.
    Conceicao, I. M.
    Schmidt, H.
    Trigo, P.
    Packman, J.
    Grogan, D. R.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 75 - 76
12345